Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.280 USD | 0.00% |
|
-4.28% | -4.94% |
Feb. 06 | Wedbush Adjusts Kura Oncology's Price Target to $26 From $34, Maintains Outperform Rating | MT |
Feb. 05 | Kura Oncology, Inc., Kyowa Kirin Co., Ltd. - Special Call |
Capitalization | 644M 613M 578M 511M 912M 55.78B 1.01B 6.88B 2.55B 23.32B 2.41B 2.37B 97.91B | P/E ratio 2024 * |
-4.62x | P/E ratio 2025 * | -4.45x |
---|---|---|---|---|---|
Enterprise value | 248M 236M 223M 197M 352M 21.51B 390M 2.65B 983M 8.99B 931M 912M 37.75B | EV / Sales 2024 * |
4.28x | EV / Sales 2025 * | 2.44x |
Free-Float |
-
| Yield 2024 * |
-
| Yield 2025 * | - |
Last Transcript: Kura Oncology, Inc.
1 week | -4.28% | ||
Current month | +4.68% | ||
1 month | +15.32% | ||
3 months | -47.99% | ||
6 months | -56.99% | ||
Current year | -4.94% |







Director | Title | Age | Since |
---|---|---|---|
Troy Wilson
CEO | Chief Executive Officer | 56 | 2014-08-21 |
Francis Burrows
CTO | Chief Tech/Sci/R&D Officer | - | 2025-01-01 |
Mollie Leoni
CTO | Chief Tech/Sci/R&D Officer | - | 2025-01-01 |
Manager | Title | Age | Since |
---|---|---|---|
Troy Wilson
CHM | Chairman | 56 | 2015-02-28 |
Faheem Hasnain
BRD | Director/Board Member | 66 | 2015-04-26 |
Thomas Malley
BRD | Director/Board Member | 56 | 2015-10-13 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.09% | 0 M€ | 0.00% | - | |
0.08% | 0 M€ | 0.00% | - | |
0.05% | 0 M€ | -.--% | - |
Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
---|---|---|---|---|---|---|
0.00% | -4.28% | -59.84% | -40.65% | 644M | ||
-0.77% | -2.20% | +8.72% | +94.68% | 118B | ||
-0.10% | -5.13% | -28.95% | +6.77% | 72.09B | ||
-2.13% | -3.83% | +68.23% | +140.90% | 38.79B | ||
-2.40% | +1.89% | +30.72% | -27.59% | 28.73B | ||
+2.38% | +3.29% | +55.74% | +4.84% | 24.63B | ||
+4.61% | +2.25% | +11.97% | -39.14% | 23.61B | ||
-2.06% | +6.27% | +321.50% | +903.29% | 15.76B | ||
+0.81% | -0.80% | +168.76% | +230.46% | 14.19B | ||
+0.94% | +8.59% | -19.89% | -31.61% | 13.46B | ||
Average | +0.13% | +0.53% | +55.69% | +124.20% | 34.98B | |
Weighted average by Cap. | -0.26% | -1.16% | +32.25% | +93.12% |
2024 * | 2025 * | |
---|---|---|
Net sales | 57.96M 55.18M 52.04M 45.96M 82.12M 5.02B 91.13M 620M 230M 2.1B 217M 213M 8.81B | 82.44M 78.48M 74.02M 65.38M 117M 7.14B 130M 881M 327M 2.99B 309M 303M 12.54B |
Net income | -153M -146M -138M -122M -217M -13.29B -241M -1.64B -608M -5.56B -575M -564M -23.33B | -165M -157M -148M -131M -233M -14.27B -259M -1.76B -652M -5.97B -617M -605M -25.04B |
Net Debt | -396M -377M -355M -314M -561M -34.27B -622M -4.23B -1.57B -14.33B -1.48B -1.45B -60.16B | -443M -421M -397M -351M -627M -38.34B -696M -4.73B -1.75B -16.03B -1.66B -1.63B -67.29B |
Date | Price | Change | Volume |
---|---|---|---|
25-02-14 | 8.280 $ | 0.00% | 815,081 |
25-02-13 | 8.280 $ | -0.84% | 699,131 |
25-02-12 | 8.350 $ | +0.12% | 805,856 |
25-02-11 | 8.340 $ | -5.12% | 1,928,345 |
25-02-10 | 8.790 $ | +1.62% | 1,106,788 |
Delayed Quote Nasdaq, February 14, 2025 at 04:00 pm EST
More quotes
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- KURA Stock